动脉粥样硬化作为炎症性肠病危险因素:一项基于人群的病例对照研究
该全国性病例对照研究利用瑞典患者登记和病理报告强化流行病学队列,纳入2002至2021年成人新发炎症性肠病(IBD)病例,每例匹配最多10名一般人群对照,采用条件logistic回归计算IBD诊断前暴露于动脉粥样硬化相关疾病的比值比(OR)。共纳入56,212例IBD患者和531,014名对照,2,334例(4.2%)病例和18,222名(3.4%)对照有既往动脉粥样硬化相关疾病诊断,对应OR为1.30(95%CI 1.24-1.37)。
要点
- IBD诊断前有动脉粥样硬化相关疾病史者,发生IBD的OR为1.30(95%CI 1.24-1.37)。
- 克罗恩病OR为1.37(95%CI 1.26-1.48),溃疡性结肠炎OR为1.27(95%CI 1.20-1.35)。
- 关联在40-59岁和60岁及以上发病者中显著,诊断前6-12个月OR最高,≥5年前仍升高。
核心结论
- 有动脉粥样硬化相关疾病史与发生IBD的 odds 升高相关,尤其在年龄较大成人中。
- 未来研究应探讨针对动脉粥样硬化相关炎症的药物是否可在高风险个体中预防IBD。
研究设计与样本
- 全国性病例对照研究,使用瑞典患者登记和瑞典病理报告强化流行病学队列。
- 纳入2002至2021年间成人新发IBD病例,每例匹配最多10名一般人群对照。
- 采用条件logistic回归计算暴露于动脉粥样硬化相关疾病(心肌梗死、血栓栓塞性卒中或动脉粥样硬化本身)后诊断IBD的OR。
- 共56,212例IBD患者和531,014名对照。
主要发现
- 2,334例(4.2%)病例和18,222名(3.4%)对照有既往动脉粥样硬化相关疾病诊断,OR为1.30(95%CI 1.24-1.37)。
- 克罗恩病OR为1.37(95%CI 1.26-1.48),溃疡性结肠炎OR为1.27(95%CI 1.20-1.35),均达统计学显著。
- 在40-59岁和60岁及以上发生IBD的个体中结果显著。
- 调整包括免疫介导疾病及既往阿司匹林和/或他汀使用在内的基础合并症后,关联持续存在。
- IBD诊断前6-12个月动脉粥样硬化相关疾病的 odds 最高,但≥5年前 odds 仍升高;有2种或以上动脉粥样硬化相关疾病时 odds 幅度高于仅有1种。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Data suggest atherosclerotic-related inflammation may play a role in the pathogenesis of inflammatory bowel disease (IBD), but large-scale studies are missing. METHODS: In this nationwide case-control study, we used the Swedish Patient Register and the Epidemiology Strengthened by histoPathology Reports in Sweden cohort to identify adult cases of incident IBD between 2002 and 2021, with each case matched to up to 10 general population controls. We used conditional logistic regression to calculate odds ratios (OR) for exposure to an atherosclerotic-related condition (myocardial infarction, thromboembolic stroke, or atherosclerosis itself) before being diagnosed with IBD. RESULTS: There were a total of 56,212 individuals with IBD and 531,014 controls. Of them, 2,334 (4.2%) cases and 18,222 (3.4%) controls had a prior diagnosis of an atherosclerotic-related condition, corresponding to an OR of 1.30 (95% confidence interval [CI] 1.24-1.37). Results were statistically significant for both Crohn's disease (OR 1.37, 95% CI 1.26-1.48) and ulcerative colitis (OR 1.27, 95% CI 1.20-1.35) and for individuals who developed IBD at 40-59 years of age and 60 years or older. In addition, associations persisted when adjusting for underlying comorbidities, including the presence of immune-mediated diseases and prior aspirin and/or statin use. The highest odds of an atherosclerotic-related condition were seen in the 6-12 months before IBD diagnosis, though odds were increased even ≥5 years before. A higher magnitude of odds was also observed when having 2 or more atherosclerotic-related conditions when compared with having only 1 condition. DISCUSSION: A history of an atherosclerotic-related condition is associated with increased odds of developing IBD, particularly among older adults. Future studies should investigate whether drugs targeting atherosclerotic-related inflammation may prevent IBD in higher-risk individuals.
引用
- Faye AS, Axelrad JE, Sun J, et al. Atherosclerosis as a Risk Factor of Inflammatory Bowel Disease: A Population-Based Case-Control Study. Am J Gastroenterol. 2023. PMID: 37721310. doi:10.14309/ajg.0000000000002502
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。